DEMANT Stock Overview
Operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | DKK 270.00 |
52 Week High | DKK 373.50 |
52 Week Low | DKK 247.90 |
Beta | 0.98 |
11 Month Change | 8.26% |
3 Month Change | -18.33% |
1 Year Change | -6.22% |
33 Year Change | -23.77% |
5 Year Change | 32.09% |
Change since IPO | 1,493.67% |
Recent News & Updates
Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Jul 14Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today
Jun 30At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?
Jun 16Recent updates
Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Jul 14Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today
Jun 30At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?
Jun 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price
Jun 03We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
May 22Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?
Dec 17Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital
Oct 31Is Demant (CPH:DEMANT) Using Too Much Debt?
Oct 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Oct 01Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital
Jul 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Jul 11A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jun 26Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly
Jun 13Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Apr 18Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?
Apr 04Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?
Mar 21These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well
Mar 08Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 06Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Nov 22We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
Oct 04Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?
Sep 20Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price
Sep 07What Is Demant A/S's (CPH:DEMANT) Share Price Doing?
Aug 19Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital
Jul 18Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Jun 22Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jun 09If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
May 28Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
May 16Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value
Apr 09Is Demant (CPH:DEMANT) A Risky Investment?
Mar 16Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why
Mar 03Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?
Mar 01Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?
Feb 17What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?
Feb 05Capital Investment Trends At Demant (CPH:DEMANT) Look Strong
Jan 05Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?
Dec 08Estimating The Fair Value Of Demant A/S (CPH:DEMANT)
Nov 13Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Oct 31Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Oct 04These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely
Sep 08Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?
Jul 26Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Jun 27Is Demant (CPH:DEMANT) Using Too Much Debt?
May 31Estimating The Intrinsic Value Of Demant A/S (CPH:DEMANT)
May 03Should You Investigate Demant A/S (CPH:DEMANT) At kr.305?
Apr 19Investors Could Be Concerned With Demant's (CPH:DEMANT) Returns On Capital
Mar 23Shareholder Returns
DEMANT | DK Medical Equipment | DK Market | |
---|---|---|---|
7D | 2.8% | 0.7% | -0.3% |
1Y | -6.2% | 11.3% | 25.4% |
Return vs Industry: DEMANT underperformed the Danish Medical Equipment industry which returned 15.6% over the past year.
Return vs Market: DEMANT underperformed the Danish Market which returned 27.3% over the past year.
Price Volatility
DEMANT volatility | |
---|---|
DEMANT Average Weekly Movement | 5.3% |
Medical Equipment Industry Average Movement | 5.7% |
Market Average Movement | 4.3% |
10% most volatile stocks in DK Market | 9.1% |
10% least volatile stocks in DK Market | 2.8% |
Stable Share Price: DEMANT's share price has been volatile over the past 3 months.
Volatility Over Time: DEMANT's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1904 | 21,501 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
DEMANT fundamental statistics | |
---|---|
Market cap | DKK 58.78b |
Earnings (TTM) | DKK 2.54b |
Revenue (TTM) | DKK 22.84b |
23.2x
P/E Ratio2.6x
P/S RatioIs DEMANT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DEMANT income statement (TTM) | |
---|---|
Revenue | DKK 22.84b |
Cost of Revenue | DKK 5.80b |
Gross Profit | DKK 17.04b |
Other Expenses | DKK 14.50b |
Earnings | DKK 2.54b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 11.64 |
Gross Margin | 74.61% |
Net Profit Margin | 11.10% |
Debt/Equity Ratio | 137.5% |
How did DEMANT perform over the long term?
See historical performance and comparison